LEP has been proposed as a culprit for obesity-induced cancer because it displays epigenetic variation and is involved in energy homeostasis, immune responses, angiogenesis and insulin signaling (Franckhauser et al., 2006). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.